Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe adverse event
affecting patients with cancer and patients with osteoporosis who have been treated with …

The medication-related osteonecrosis of the jaw (MRONJ) is believed to be a therapy-
resistant entity. Although the application of the recommended conservative and surgical …

Introduction Scientific debate outlines tooth extraction as a potential trigger for the onset of
bisphosphonate-related osteonecrosis of the jaw (BRONJ). Therefore, the aim of this study …

Root amputation, extraction of a single tooth, bone loss or severe tooth mobility, and an
unclosed wound were significantly associated with increased risk of developing medication …

Osteonecrosis of the jaws (ONJ) is a complication of antiresorptive medications, such as
denosumab or bisphosphonates, prescribed to patients with bone malignancy or …

Background: Nearly two decades have passed since a paradoxical reaction in the orofacial
region to some bone modifying agents and other drugs was recognized, namely medication …

Objective To assess the outcomes of several rodent animal models for studying tooth
extraction-related medication-related osteonecrosis of the jaw (MRONJ). Design After a …

Objective This study was performed to determine whether the results of prevailing in vivo
and in vitro studies offer a reliable model for investigation of medication-related …

This study compiles the main hypotheses involved in the etiopathogenesis of medication-
related osteonecrosis of the jaw (MRONJ). A narrative review of the literature was …

Background Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is a complication of
the bisphosphonate (BP) treatment and its pathopysiology is still not fully understood. The …